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Abstract
Baltic ringed seals (Phoca hispida baltica) and grey seals (Halichoerus grypus) live in one of the most
polluted water basins of the world, namely the Baltic Sea. Since the late 1960s, the seals have been
suffering from a heavy contaminant load consisting mainly of polyhalogenated aromatic hydrocar-
bons (PHAHs) and heavy metals. The elevated levels of PHAHs, especially polychlorinated biphenyls
(PCBs) and metabolites of 1,1,1-trichloro-2,2-bis[p-chlorophenyl]ethane (DDT), have been associ-
ated with a number of pathological changes in the seals. However, the mechanisms linking the ob-
served pathological lesions with the contaminant load are not known. Many PHAHs are persistent,
man-made compounds that biomagnify and bioaccumulate along the food chain. Marine mammals are
especially vulnerable to PHAH exposure, as they are predators at the top of the food chain, and be-
cause their large blubber mass acts as a reservoir for these lipophilic compounds. Biological markers
(biomarkers), that reflect the exposure levels or toxic effects of the contaminant load in wildlife
populations, can be used to assess the impact of the total individual pollution load without having to
perform cumbersome chemical analyses. This study was conducted to test potential biomarkers for
assessing the exposure and toxic effects of the contaminant load in Baltic seals. We investigated
cytochrome P450 (CYP) enzymes, the toxic potency of the internal load of dioxin-like compounds
(measured by chemical-activated luciferase gene expression, CALUX), vitamin A and vitamin E lev-
els, and haematological and blood chemistry parameters as potential biomarkers. Furthermore, the two
species were compared in terms of susceptibility and response to the contaminant load, and of their
metabolising capacity. Samples from ringed and grey seals living in less polluted waters were used as
reference material in terms of the pollution load. Ringed seals were sampled from the European Arctic
Ocean (Svalbard) and grey seals were sampled from the Western Atlantic Ocean (Sable Island, Canada).
Higher levels of CYP1A expression and vitamin E in the Baltic seals than in the reference seals
showed a positive correlation with the individual sum PCB and sum DDT load, suggesting that they
could serve as exposure biomarkers for these types of compounds in both species of Baltic seal. The
results revealed that CALUX apparently reflects the whole PCB and DDT burden in ringed seals in
this particular situation. In grey seals, hepatic and blubber retinyl palmitate (vitamin A) levels may be
potential biomarkers for the depletion of vitamin A stores. However, as the vitamin A and E balance in
animals is clearly affected by the quantity of vitamin available from food sources, information about
the dietary vitamin A and E levels is needed before any conclusions can be drawn. None of the clinical
blood parameters investigated can be proposed as a biomarker for the toxic effects of PHAHs. A
species comparison of the susceptibility and response to the contaminant load showed that grey seals
probably have a greater capacity to react to an increasing PHAH exposure, than ringed seals. Further-
more, the two species respond in different ways to the contaminant load which results in species-
specific toxic effects. The health status and contaminant exposure and effects should, therefore, be
monitored separately in each seal species.
Key words: Baltic Sea, ringed seal, grey seal, CYP, PHAH, biomarker, vitamins, blood, CALUX
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Biomarkörer för exponeringen och för de toxiska effekterna
av polyhalogenerade aromatiska kolväten
i Östersjöns vikare och gråsälar
Abstrakt
Östersjöns vikare (Phoca hispida baltica) och gråsälar (Halichoerus grypus) lever i ett av världens
mest nedsmutsade hav. Alltsedan 1960-talet har sälarana haft en hög giftbörda bestående huvudsakligen
av polyhalogenerade koväten och tungmetaller. De höga koncentrationerna av polyhalogenerade
koväten, speciellt polyklorerade bifenyler (PCB) och 1,1,1-trikloro-2,2-bis[p-klorofenyl]etan (DDT)
och dess metaboliter, korrelerar med en mängd patologiska förändingar som är typiska för
Östersjösälarna. Mekanismerna som sammanlänkar de patologiska förändringarna med den höga
giftbördan är myckket dåligt kända. Flertalet polyhalogenerade koväten är syntetiska klorofenyl-etane
föreningar som bryts ned mycket långsamt i naturen och som anrikas längs med näringskedjan. Marina
däggdjur är speciellt exponerade för dessa ämnen: de är predatorer i övre ändan av näringskedjan och
deras tjocka späcklager fungerar som en upplagringsplats för dessa fettlösliga ämnen. Biologiska
markörer (biomarkörer), som avspeglar exponeringsgraden eller de toxiska effekterna av giftbördan,
kan användas för att uppskatta den totala inverkan av giftbördan i en organism utan tidskrävande och
dyra kemiska analyser. I denna studie sökes potentiella biomarkörer för att uppskatta exponeringen
och de toxiska effekterna av giftbördan i Östersjösälarna. Vi undersökte användningen av cytokrom
P450 (CYP) enzym, av giftpotensen av dioxin-lika ämnen användades kemiskt-aktiverad lusiferas
gen-expression (CALUX), av A och E vitamin samt av hematologiska och kemiska blodparametrar
som potentiella biomarkörer. Gråsälens och vikarens känslighet för och reaktion mot giftbördan
jämfördes. Därtill jämfördes deras kapacitet att bryta ner gifter. Som referensmaterial användes vävnader
tagna från vikare och gråsälar som lever i mindre nedsmutsade områden (Svalbard i Arktis, och Sable
Island i Kanada). En högre CYP1A expression och en högre halt av E vitamin i Östersjösälarna jämfört
med referenssälarna korrelerade positivt med den indivduella PCB- och DDT-halten, vilket antyder att
dessa parametrar kunde användas som exponeringsmarkörer för PCB och DDT i Östersjösälarna.
Resultaten visade att CALUX kunde föreslås som exponeringsmarkör för både PCB och DDT i vikare.
För gråsäl föreslås halten av retinylpalmitat (A vitamin) i späck eller lever som potentiell biomarkör
för uttömningen av A vitaminförråden. Eftersom både A och E vitaminbalansen i däggdjur klart påverkas
av mängden vitaminer i födan krävs mera information om födans A och E vitaminmängd hos sälarna
innan slutsater kan dras om dessa parametrars användning som biomarkörer. Av de undersökta kliniska
blodparametrarna kan ingen föreslås som biomarkör, men dessa kan istället användas för att indikera
det allämnna hälsotillståndet hos sälarna. Jämförelsen mellan de två arterna visade att gråsälar troligen
har en bättre kapacitet att aktivera nedbrytningsprocessen av polyhalogenerade koväten. Därtill reagerar
de två arterna olika på giftbördan, vilket leder till artspecifika toxiska effekter. Hälsotillståndet,
giftexponeringen och de toxiska effekterna bör därför uppföljas separat för gråsäl och vikare i Östersjön.
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Abbreviations
AFOS Alkaline phosphatase
AhR Aryl hydrocarbon receptor
ALAT Alanine aminotransferase
ASAT Aspartate aminotransferase
BNF β-Naphthoflavone
CALUX Chemical-activated luciferase gene expression
CALUX-TEQ TCDD-equivalence of the CALUX response
C-6-OH Chlorzoxazone 6-hydroxylase
COH Coumarin 7-hydroxylase
CYP Cytochrome P450
DOM Dexromethorphan O-demethylase
EROD Ethoxyresorufin O-deethylase
HCB Hexachlorobenzene
HCH Hexachlorocyclohexane
HPLC High performance liquid chromatography
LD Lactate dehydrogenase
3-MC 3-Methylcholanthrene
PAH Polynuclear aromatic hydrocarbon
PB Phenobarbital
PBB Polybrominated biphenyl
PBDE Polybrominated diphenyl ether
PCB Polychlorinated biphenyl
PCDD Polychlorinated dibenzo-p-dioxin
PCDE Polychlorinated diphenyl ether
PCDF Polychlorinated dibenzofuran
PCN Pregnenolone-α-carbonitrile
PHAH Polyhalogenated aromatic hydrocarbon
p,p´-DDD 1,1-dichloro-2,2-bis[p-chlorophenyl]ethane
p,p´-DDT 1,1,1-trichloro-2,2-bis[p-chlorophenyl]ethane
p,p´-DDE 1,1-dichloro-2,2-bis[p-chlorophenyl]ethylene
PROD Pentoxyresorufin O-depentylase
TCDD 2,3,7,8-tetrachlorodibenzo-p-dioxin
TEBH Testosterone 6ß-hydroxylase
TEF TCDD toxic equivalency factor
TEQ TCDD toxic equivalent concentration
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1. Introduction
The Baltic Sea is one of the most polluted bodies
of water in the world. The extremely high levels
of chlorinated organic contaminants that were
found in the Baltic sediment and biota over three
decades ago, have been associated with a number
of pathological changes and reproductive impair-
ments in various wildlife species inhabiting this
region (Helle et al. 1976a, b, Bergman and Olsson
1986, Helander et al. 1982, Bengtson et al. 1999).
Although the contaminant levels have decreased
since their peak in the 1970s, they will remain
high for a long time and levels of some compounds
like polychlorinated biphenyls (PCBs) are even
expected to increase over time (Tanabe 1988,
Jonsson et al. 1996).
The need to detect and assess the effects of
pollutants at an early stage, before irreversible
changes have taken place, has driven the devel-
opment of biomarkers. ‘A biomarker is a xeno-
biotically-induced variation in cellular or bio-
chemical components or processes, structures or
functions that is measurable in a biological sys-
tem or sample’ (NRC 1987). “Exposure biomark-
ers” reflect exposure to chemicals, while “effect
biomarkers” reflect the toxic effects of a chemi-
cal exposure.
This introduction will present an overview of
the characteristics and problems of the Baltic Sea
and of the Baltic ringed seals (Phoca hispida balt-
ica) and grey seals (Halichoerus grypus). This will
be followed by a general discussion on the occur-
rence and toxicity of polyhalogenated aromatic
hydrocarbons (PHAHs) in the aquatic environ-
ment. Furthermore, a set of biomarkers commonly
used in aquatic toxicology will be described in
relation to being potential biomarkers for assess-
ing the exposure and effects of the PHAH load on
the Baltic seals.
1.1. The Baltic Sea
The Baltic Sea is a relatively young and shallow
water basin. Since the last glacial period ended
about 11 000 years ago, the Baltic basin has peri-
odically shifted between a fresh water lake and a
marine sea (Wahlström et al. 1992). The Baltic
Sea as it is today, the world’s largest brackish
water basin (< 1% salinity), was formed around
3000 years ago. Due to its colourful history the
Baltic Sea contains a mixture of marine and fresh
water organisms. There is little species diversifi-
cation and many of the species are living at the
edge of their area of biogeographic distribution
and of their physiological tolerance. Thus, the
Baltic ecosystem is fragile and sensitive to dis-
turbances. The catchment area of the Baltic Sea is
4.3 times larger than the water basin itself, with
more than 250 larger rivers running into it (Wahl-
ström et al. 1992). The enormous amounts of water
draining into the Baltic Sea from industrialised
and rural areas carry both natural and anthropo-
genic matter.
It was first recognised during the 1960s that
the Baltic Sea was contaminated with toxic com-
pounds that affect the ecosystem (Jensen et al.
1969, Jensen 1972). Most of the biota, including
the Baltic seals, were suffering from a heavy con-
taminant load (Jonsson et al 1996, Bignert et al.
1998). Exceptionally high mean total concentra-
tions of PCBs and 1,1,1-trichloro-2,2-bis[p-
chlorophenyl]ethane (DDT) in blubber of over 100
mg/kg (lipid weight) were reported in Baltic seals
in the late 1960s and the 1970s (Jensen et al. 1969,
Helle et al. 1976a, b). Since PCBs and DDT have
been banned in the countries around the Baltic
Sea, DDT levels, especially, have decreased in
the Baltic ecosystem (Bignert et al. 1998). How-
ever, pollutant levels are still high enough to cause
a threat to the aquatic ecosystem, and the con-
taminants in the sediment will remain a substan-
tial source of pollution in the aquatic environment
for a long time (Jonsson et al. 1996). During the
last decade, high levels of PCBs, especially, have
been measured in fish and bird eggs in the Baltic
Sea environment, while levels of DDTs,
hexachlorocyclohexane (HCH), hexachloroben-
zene (HCB), chlorobornanes (Toxaphene) and
chlordanes have decreased to levels similar to
those in other marine environments (Paasivirta et
al. 1993, Vuorinen et al. 1997, Bignert et al. 1998).
Today, eutrophication is receiving more and
more attention as another serious concern for the
Baltic ecosystem (Larsson et al. 1985). The rapid
increase in primary production has resulted in al-
gal blooms and expanding oxygen-depleted ar-
eas. A contributing cause to the lack of oxygen
has been the absence of major incoming pulses of
Nyman10
oxygen-rich marine water through the Danish
Straits over the last two decades (Matthäus and
Schinke 1994).
1.2. Baltic ringed and grey seals
Ringed seals (Phoca hispida) are widespread and
abundant in the Arctic and Subarctic Oceans. Sev-
eral different subspecies have been described in
addition to the arctic Phoca hispida hispida. Sub-
species of ringed seals occur in the Baltic Sea,
Lake Saimaa (P.h. saimensis), Lake Ladoga (P.h.
ladogensis) and the Sea of Okhotsk (P.h.
ochotensis). Their distribution is mainly depend-
ent on the ice conditions. The Baltic, Saimaa and
Ladoga ringed seals are remnants of the last gla-
ciation (Reeves et al. 1992). For a few thousand
years, they were trapped in their respective water
basins. The Baltic ringed seals occur primarily in
areas with consolidated and ridged ice during
March–May (Bothnian Bay and Eastern Gulf of
Finland), where they breed. Of a roughly estimated
world-wide population of several million ringed
seals, the haulout population in the Baltic Sea is
approximately 5500 (Härkönen et al. 1998). The
haulout population represents only the part of the
population that can be counted on the ice.
The drastic reduction in the population of seals
in the Baltic Sea (estimations of 100 000–200 000
seals at the beginning of the 1900s to a few thou-
sand in the mid 1980s) has been explained by ex-
tensive hunting, and later by the heavy contami-
nant load of the Baltic seals (Hårding and Härkö-
nen 1999, Kokko et al. 1999). The unexpectedly
slow recovery of the population since this period
has been due to pathological changes in the uterus,
leading to life-long sterility (Helle et al. 1976 a, b,
Bergman and Olsson 1986, Bergman et al. 1992).
These deformations have been associated with the
contaminant load although exactly how the con-
taminants cause the deformations is not known.
Ringed seals are solitary animals during win-
ter, inhabiting their ice territories and maintain-
ing their breathing holes (Reeves et al. 1992). In
February and March, the females give birth in
snow-covered lairs and nurse their pups for 5–7
weeks. Mating occurs around the time of wean-
ing. The implantation of the foetus is delayed for
three months, after which the post-implantation
gestation lasts roughly nine months. Baltic females
become sexually mature at 3 years and males a
few years later (Eero Helle pers. comm.). Adult
ringed seals reach a maximum weight of over 100
kg, but the weight varies considerably both geo-
graphically and seasonally (Reeves et al. 1992).
Baltic ringed seals moult in April and May in small
groups or alone on the ice. During this period the
seals greatly reduce their feeding activity and can
loose up to half of their weight.
Grey seals are distributed in the North Atlan-
tic Ocean and in the Baltic Sea. The population
size in the Western Atlantic is estimated to 154
000 animals, with the seals occurring mainly in
the area around Sable Island and in the Gulf of St.
Lawrence; and in the Eastern Atlantic to 130 000–
140 000 seals (http://www.greenchannel.com/tec/
species/species.htm). The Baltic population, which
was thought to be around 100 000 seals at the be-
ginning of the 1900s (Hårding and Härkönen 1999,
Kokko et al. 1999), is estimated to have fallen to
around 2000 in the 1970s (Almkvist 1978). This
drastic decline in population has been followed
by a recent recovery in the number of grey seals,
to at least 7 600 counted seals, as a result of a
more or less normal level of reproductivity (ICBS
1999). An increase in a variety of pathological
changes in the Baltic grey seals and, to a lesser
extent, in ringed seals was first recorded during
the 1960s (Bergman and Olsson 1986, Bergman
et al. 1992, Mortensen et al. 1992, Lind 2000).
The specific disease syndrome, including ulcers,
renal failure, adrenocortical hyperplasia, skull le-
sions, leiomyomas and reproductive impairments,
has been associated with the high levels of PHAHs
found in the tissues of these animals (Bergman
and Olsson 1986). The nature of the disease com-
plex indicates a disturbance of the endocrine sys-
tem caused by the contaminants. PCBs and DDT
and their metabolites have been shown to inter-
fere with the adrenal function in vitro, indicating
that these types of compounds may have been in-
volved in the disease syndrome (Brandt et al. 1992,
Lund 1994, Johansson et al. 1998). Today, the
health status of the grey seals has improved al-
though an increase in ulcers has been reported es-
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pecially in young males (Bergman 1999).
Grey seals are social and gather together dur-
ing breeding, moulting and hauling out. In the
Baltic Sea, they breed between February and April
and moult in April, May and June. The seals live
mainly on their fat reserves during breeding and
moulting because they reduce their feeding activ-
ity during this period. Reproduction is similar to
that of the ringed seals with a delayed implanta-
tion and a post-implantation gestation of roughly
nine months. Pups are born in February and March
and are nursed for about 18 days with milk that is
nutritious and lipid-rich. In the Baltic population,
females reach sexual maturity at 3–5 years and
males at 4–6 years. Grey seals are clearly larger
in size than ringed seals, females commonly
weighing 100 kg and males slightly more.
Both seal species are opportunistic feeders and
prey on a variety of food sources, ranging from
fish to crustaceans and planktonic amphipods
(Tormosov and Rezvov 1978, Lowry et al. 1980,
Gjertz and Lydersen 1986, Smith 1987, Reeves
et al. 1992, Bowen and Harrison 1994, Weslawski
et al. 1994). In the Baltic Sea they feed roughly at
the same trophic level of the food web. The ringed
seals feed mainly on Baltic herring (Clupea
harengus), European smelt (Osmerus eperlanus),
whitefish (Courageous lavaretus) and crustaceans
(Saduria entomon and Mysis relicta) (Söderberg
1974, Tormosov and Rezvov 1978), whereas the
grey seals feed on Baltic herring, European smelt,
eelpout (Zoarces viviparus), cod (Gadus morhua)
and salmon (Salmo salar) (Söderberg 1974). As
the cod has disappeared from the northern parts
of the Baltic Sea due to a reduction in salinity
(Aro 2000), the grey seals have shifted their diet
towards the other prey species (Olavi Stenman
pers. comm.). By comparison, grey seals living
in the Western Atlantic Ocean prey mainly on sand
lance (Amnodytes dubius), Atlantic cod and flat-
fish (Pleuronectiformes) (Bowen and Harrison
1994). The food sources of the ringed seals from
the European Arctic differ from their Baltic rela-
tives, the main prey species being Arctic cod
(Boreogadus saida), redfish (Sebaster sp) and
some crustacean species (Pandalus borealis,
Thysanoessa inermis and Parathemisto libellula)
(Gjertz and Lydersen 1986, Weslawski et al. 1994).
1.2.1. What is causing the reduction in the
health status of the Baltic seals?
Extremely high levels of both persistent organic
pollutants and of heavy metals have been meas-
ured in Baltic seals. Mercury concentrations ex-
ceeding 100 mg/kg fresh liver weight were meas-
ured in Baltic seals in the 1970s (Herva and
Häsänen 1972, Kari and Kauranen 1978, Helle
1981, Perttilä et al. 1986). Since then, no clear
pattern of a decrease in levels of mercury or other
metals in the Baltic fauna has been observed
(Jonsson et al. 1996, Fant et al. 2001). However,
no clearly toxic effects have been connected to
the present metal concentrations in Baltic seals
(Fant et al. 2001). Trace elements occur naturally
and some of them are essential components of
organisms. Metals reach the marine environment
both through natural weathering and through vari-
ous industrial processes. Highly elevated levels
of especially mercury (Hg), cadmium (Cd) and
lead (Pb) have received attention from aquatic
toxicologists because these metals are toxic to
humans and experimental animals (O’Shea 1999).
Furthermore, Hg and Cd tend to biomagnify along
the food chain. Very little data are available on
the toxicity of metals in marine mammals (re-
viewed by O’Shea 1999). It has even been sug-
gested that marine mammals have adapted to high
burdens of the metals that occur naturally (Dietz
et al. 1998). Marine mammals, as well as many
other organisms, can protect themselves from
metal toxicity with metal binding proteins such
as metallothionein (O’Shea 1999).
Several different groups of persistent organic
pollutants have been found in the Baltic ringed and
grey seals, including PCBs, DDTs, HCH, HCB,
polybrominated biphenyls (PBBs), Toxaphene,
chlordanes, polychlorinated dibenzo-p-dioxins
(PCDDs), polychlorinated dibenzofurans (PCDFs),
polychlorinated diphenyl ethers (PCDEs) and poly-
brominated diphenyl ethers (PBDEs) (Andersson
and Wartanian 1992, Bergek et al. 1992, Blomkvist
et al. 1992, Koistinen et al. 1997). When summa-
rising this data, PCBs and DDT together with their
metabolites are the dominating organic pollutants,
and are thought to be the greatest threat to the Bal-
tic seals (Olsson et al. 1992, Jaana Koistinen pers.
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comm.). On the other hand, possible synergistic and
additive effects of the other organohalogen com-
pounds should not be excluded.
In addition to the Baltic seal case, a number of
studies have suggested that organic pollutants have
a detrimental effect on other marine mammals.
Yet very few of them have been able to pinpoint
the exact toxic mechanisms leading to the ob-
served impairments. However, increasing knowl-
edge about the adverse effects of numerous envi-
ronmental compounds on experimental animals
supports the association between a heavy load of
persistent organic pollutants and pathological
changes in marine mammals.
1.3. PHAHs in the aquatic environment
Anthropogenic chemical compounds and trace
elements reach the aquatic systems through run-
off, leakage, dumping and atmospheric transport.
The persistent compounds biomagnify and
bioaccumulate along the food webs reaching their
peaks in organisms at the top of the food chain.
Contaminants tend to accumulate especially in
aquatic carnivorous species, such as seals that feed
at high trophic levels, and can reach very high
levels (Tanabe 1988). Among the antropogenic
products in the aquatic environment, PHAHs have
caused the most concern.
PHAHs are a group of synthetic organic com-
pounds that have been produced for industrial and
agricultural purposes. Many of these compounds
are fat-soluble (lipophilic) and persistent, and ac-
cumulate in the fat layers of organisms. Among
the PHAHs, PCBs, PCDDs, PCDFs and DDTs
have received most attention due to their chemi-
cal stability and persistence in the environment,
and to their toxic effects on several species in-
cluding man.
The PCBs, a group of 209 different organo-
chlorine compounds (congeners), have been used
world-wide in large quantities since the 1930s, in
capacitors, plastics, electrical transformers, paints,
inks and as fire retardants (Tanabe 1988, Safe
1994). They have a general chemical structure of
one biphenyl ring into which varying numbers of
chlorine atoms are incorporated (Figure 1A). The
congeners are identified by their specific IUPAC
number that describes the number and location of
the chlorine atoms (Erickson 1997). The PCB con-
geners can be divided into three groups accord-
ing to their configuration: non-ortho-PCBs with
no chlorine atoms in the ortho positions; mono-
ortho-PCBs with one chlorine atom in the ortho
position; and di-ortho-PCBs with two chlorine
atoms in the ortho positions. Although the use of
PCBs has been banned in Western Europe and
North America since the 1970s they are still re-
leased into the aquatic system by leaking and de-
grading systems and are distributed to remote ar-
eas through atmospheric transport (reviewed by
Tanabe et al. 1994, and by Letcher 1996). In 1988,
one third (31%) of the global production of PCBs
was estimated to have reached the oceans (Tanabe
1988).
The insecticide DDT and its metabolites were
first reported in marine mammals in the 1960s, at
the time when DDT was associated with the egg-
shell thinning that was causing population declines
in raptorial birds (reviewed by O’Shea 1999).
During this time, it was first recognised that syn-
thetic organic compounds can cause a threat to
the environment. The parent compound DDT is
not as persistent as its metabolites 1,1-dichloro-
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Figure 1. Chemical structure of (A) PCBs and (B) p,p´-
DDT
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2,2-bis[p-chlorophenyl]ethylene (DDE) and 1,1-
dichloro-2,2-bis[p-chlorophenyl]ethane (DDD)
and therefore it often represents only a minor part
of the total DDT load in the organisms. The pp´-
isomers of the DDT derivatives are the most com-
monly occurring forms (Figure 1B). Although the
use of DDT has been restricted in Canada, USA
and Europe since the 1970s, it is still used in Asia,
Africa and South America to control malaria-
spreading mosquitoes (Barrie et al. 1992).
Among the other PHAHs, PCDDs and PCDFs
form a group of compounds that are by-products
of PCBs and other industrial manufacturing, and
incomplete combustion (Safe 1990). Despite at-
tempts to prevent further release of these com-
pounds, they are still entering the environment.
Although some of these compounds are extremely
toxic, their levels are surprisingly low in the Bal-
tic seals compared to the levels found in their main
prey species (Bergek et al. 1992, De Wit et al.
1992). The seals are therefore assumed to be able
to catabolise and rapidly eliminate PCDDs and
PCDFs, so that these compounds are not thought
to cause a threat to seals at present levels.
1.3.1. Accumulation and metabolism of
PHAHs
The level and type of contamination in any or-
ganism is dependent on the availability and de-
gradability of the contaminant. The lower halo-
genated PHAHs are generally more easily de-
graded than the higher halogenated ones. Further-
more, the accumulation pattern varies with spe-
cies, sex, feeding habits and individual metabolic
capacity. Foreign compounds (xenobiotics) are
mostly passively absorbed into the organism ac-
cording to their physico-chemical properties,
whereas their metabolism, detoxification and
elimination is an active process controlled by the
biotransformation enzymes. As most xenobiotics
are relatively new man-made substances, animals
exposed to them have not had time to evolve spe-
cific defence mechanisms. In mammals, the body
reacts to a xenobiotic in one of three ways: (1) the
compound is excreted directly; (2) the compound
is stored in the body in a form that is toxically
inactive; or (3) the compound is metabolised to a
less toxic substance. In marine mammals, li-
pophilic xenobiotics are primarily stored in the
blubber but metabolised in the liver (Tanabe et al.
1981). Although PHAHs are found primarily in
the blubber, they can be rapidly released into the
body when the fat reserves are used. Most marine
mammals undergo extensive seasonal changes in
their fat reserves because they fast during the
breeding, lactation and moulting seasons but gain
weight during the intervening seasons. Therefore,
the contaminant levels and their potential adverse
effects vary with season, age, sex and reproduc-
tive status. In general, immature animals and
reproductively active females have lower contami-
nant levels, while the concentrations increase with
age in adult males and non-reproductive females
(reviewed by O’Shea 1999). Reproductively ac-
tive females transfer the major part of their con-
taminant load to their offspring during pregnancy
and lactation. In some cetacean species, a female
can transfer 60 to 100% of her PCB and DDT
burden to her calf. Studies on the variation in the
contaminant load and pattern between species
have revealed that phocids and, especially, cetace-
ans have a lower capacity to metabolise certain
groups of PHAHs than polar bears or terrestrial
mammals (Tanabe et al. 1988, 1994, Boon et al.
1992). One proposed explanation is the lack of
certain xenobiotic-metabolising enzymes in these
groups of marine mammals as a result of exclu-
sively carnivorous feeding habits. Many of these
enzymes are thought to have evolved in terres-
trial mammals through the “animal–plant war-
fare”, which has provided the animals with a de-
fence against plant toxins (Gonzales and Nebert
1990, Peterle 1991).
1.3.2. Toxic effects of PHAHs
The onset and severity of the toxic effects of en-
vironmental contaminants in wildlife vary accord-
ing to the exposure level, age, species, sex and
general condition, and to the presence of other
contaminants and their metabolites. Wild animals
are exposed to a mixture of contaminants with
synergistic and antagonistic interactions between
the individual components. This fact complicates
the evaluation of the toxic potency and mecha-
nism of individual compounds. Only a few stud-
ies have been performed using environmentally
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relevant chemical mixtures and, in each case, the
presence of several groups of contaminants has
complicated the interpretation of the toxicity of
the individual chemicals.
The toxicity mechanism of only a few PCB
congeners is known (reviewed by Safe 1994, and
by Giesy and Kannan 1998). The non-ortho and
mono-ortho PCBs that acquire a planar configu-
ration express their toxicity through the aryl hy-
drocarbon receptor (AhR) (Figure 2). The activa-
tion of AhR leads to the induction of certain
xenobiotic-metabolising enzymes (especially
CYP1A1/2 and some conjugating enzymes), and
to oxidative damage (Toborek et al. 1995, Park et
al. 1996, Hennig et al. 1999, Schlezinger et al.
1999, Slezak et al. 1999, Slim et al. 1999). High
doses of planar PHAHs induce oxidative stress,
that manifest as an increased production of reac-
tive oxygen species (ROS), lipid peroxidation and
DNA damage, both in vitro and in vivo in labora-
tory animals. The exact toxicity mechanism of the
planar PHAHs is still unclear, but it has been sug-
gested that ROS exert their toxicity either through
the induction of cytochrome P450 enzymes or
through mechanisms that are independent of these
enzymes (Park et al. 1996, Schlezinger et al. 1999,
Slezak et al. 1999). The toxic action results in a
wide variety of effects in experimental animals,
such as acute lethality, hepatomegaly, fatty liver,
porphyria, body weight loss, dermal toxicity,
thymic atrophy, immunosuppression, reproduc-
tive and developmental toxicity, genotoxicity,
carcinogenesis, endocrine disruption and neuro-
toxicity in experimental animals (reviewed by Safe
1994, Brouwer et al. 1995). The liver is the most
affected organ in most species, but the toxic ef-
fects vary among species.
Very little toxicological data are available for
most of the non-planar PCB congeners, although
they are the most prevalent congeners in environ-
mental matrixes. The toxic effects of these PCB
congeners include neurotoxicity, carcinogenesis,
developmental effects and endocrine disruptions
(Brouwer et al. 1995, reviewed by Giesy and
Kannan 1998). PCB metabolites also exert vari-
ous types of toxic effects, i.e. anti-estrogenicity,
hypothyroidism, reduced plasma vitamin A and
thyroid hormone levels, disturbed adrenal func-
tion, and hepatic and reproductive toxicity (Lund
et al. 1999, reviewed by Letcher et al. 2000a).
The disruption of the endocrine system caused by
PCBs has been studied in experimental animals
and wildlife, but the great species variation in the
estrogenic/anti-estrogenic action of the individual
congeners has not allowed any general conclu-
sions to be drawn (reviewed by Hansen 1998).
The toxicity of PCBs, PCDDs or PCDFs to
both man and wildlife is assessed either from the
total chemical burden or from 2,3,7,8-tetrachloro-
dibenzo-p-dioxin (TCDD) equivalents (TEQ),
using the toxic equivalence factor (TEF) for each
compound (Safe 1994). The TEF is based on the
toxic response of rats to TCDD exposure, but this
does not necessarily parallel the responses in other
species (Van den Berg et al. 1994). The TEQ con-
cept allows one to express the summed TCDD
toxic potency for a mixture of compounds. As the
TEQ approach is based on AhR-mediated toxic-
ity, it quantifies only the toxic effects of non-ortho-
and mono-ortho-substituted PCBs and other di-
oxin-like compounds. This approach cannot there-
fore be applied to the toxic effects of non-dioxin
like compounds or to responses mediated by the
multiple toxicity mechanisms of PCBs and other
environmentally relevant xenobiotics. It should,
Toxic effects Excretion
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Figure 2. Diagram of the AhR-mediated induction of
CYP1A expression in a cell, and of the metabolism of
PHAHs by CYP1A.
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therefore, not be used as the only method for risk
and hazard assessment.
The pp´-isomers of DDT are usually associ-
ated with toxic effects (Blus 1996). In experimen-
tal animals, exposure to DDT derivatives has re-
sulted in neurotoxic and reproductive disorders
and pathological disturbances in the liver (re-
viewed by O’Shea 1999). A number of studies
have also demonstrated the estrogenic effects of
particularly o,p´-DDTs (reviewed by Bulger and
Kupfer 1983). DDT exposure elevates the levels
of several different forms of CYP enzymes simul-
taneously, including their AhR-mediated induc-
tion (Delescluse et al. 1998). However, it does
not bind to the AhRs and probably exerts its toxic
actions independently of them.
Attention has been drawn to the possible nega-
tive effects of contaminants on marine mammals
because of an increasing number of outbreaks of
disease in marine mammal populations (Kennedy
et al. 1988, Domingo et al. 1990, Bengtson et al.
1991, Hedlund Markussen and Have 1992, Mama-
ev et al. 1996, Duignan et al. 1997, Osterhaus et
al. 1997). As early as the 1960s and 1970s, there
was a growing fear about the adverse effects of
human activity on the marine mammal popula-
tions. The reproductive impairments and declin-
ing populations were associated with high bur-
dens of PHAHs in Californian sea lions (Zalophus
californianus), in Wadden Sea harbour seals
(Phoca vitulina), and in Baltic ringed seals and
grey seals (DeLong et al. 1973, Helle et al. 1976a,
b, Reijnders 1980). Since then, a high frequency
of pathological changes and abnormalities of vari-
ous forms, and an increased predisposition to in-
fectious diseases, have been associated with el-
evated contaminant levels in wild marine mam-
mal populations (Bergman and Olsson 1986,
Bergman et al. 1992, Mortensen et al. 1992,
Béland et al. 1993, Aguilar and Borrell 1994,
Martineau et al. 1994, Olsson et al. 1994, Jenssen
et al. 1995, Jepson et al. 1999). Although there is
no evidence that contaminants cause direct mor-
tality in any marine mammal population, toxic
effects on reproduction, the immune system and
hormonal and vitamin A status have been dem-
onstrated in experimental studies on harbour seals
(Reijnders 1986, Brouwer et al. 1989, De Swart
1995, Ross 1995).
1.4. Biomarkers
The storage, metabolism and elimination of
xenobiotics in marine mammals are not well un-
derstood, neither are their toxic effects. Further-
more, the amount and complexity of contaminant
exposure will probably increase in the future, as
the release of both well-known and new com-
pounds into the environment continues with un-
known consequences. On the other hand, increas-
ingly stricter regulations should lead to decreases
in the release of many new and known toxic com-
pounds.
Toxic effects are initiated in an affected indi-
vidual at the molecular level and, at an early stage
of the process, the body responds with compen-
satory reactions to maintain homeostasis. The next
stage of toxicity affects the microscopic structure
of the organs, and reduces the fitness of the indi-
vidual. Irreversible damage of the defence and
repair systems leads to the death of the individual.
This further affects the populations, and even com-
munities. Early detection of the effects of pollu-
tion is important, as elevated contaminant loads
may cause irreversible damage to entire popula-
tions or ecosystems in the long run. Biological
indicators or biomarkers can be used as early warn-
ing systems for the exposure and effects of the
combined xenobiotic load on the reproduction and
survival of an individual. If biomarkers are to be
useful tools, they should (1) be sensitive enough
for early detection of contaminant exposure and/
or toxic effects, (2) be easily and rapidly assayed,
(3) respond in a dose-dependent manner within
an exposure range that is environmentally rel-
evant, (4) be valid for the species in question, and
(5) be evaluated for possible influences by other
endogenous and exogenous factors (Depledge
1994). Biomarkers used in environmental studies
include enzymes, receptors, biogenic amines, vi-
tamins, hormones, DNA damage, porphyrins,
antioxidants, immunological, haematological and
blood chemistry parameters, reproductive cycle,
skeletal abnormalities and other pathological ef-
fects (reviewed by Peakall 1992, and by Stegeman
et al. 1992). As the measurement of most of these
parameters requires the analysis of tissues like
liver, kidney, blood or bone, sampling is often
detrimental to the animal. Moreover, since many
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marine mammal populations are vulnerable to
human interference, this approach is neither ethi-
cally nor practically desirable. Current recommen-
dations stress the development of biomarkers that
can be assessed non-invasively or with minimal
invasion (Fossi et al. 1999).
1.5. Cytochrome P450 (CYP)
1.5.1 General features
The main metabolic pathway for persistent li-
pophilic organic pollutants is a two-phase proc-
ess. The first phase, an oxidative reaction, is cata-
lysed principally by enzymes of the cytochrome
P450 (CYP) super-family, and leads to the trans-
formation of the xenobiotic into a more hy-
drophilic and excretable form (Figure 2). This bio-
transformation results in either a less toxic
metabolite, or in a more reactive metabolite with
higher toxicity than the parent compound (re-
viewed by Stegeman and Hahn 1994). In addition
to the oxidative stress mentioned previously,
PHAHs can be transformed through CYP1A meta-
bolic pathways into carcinogenic adducts or toxic
metabolites. The CYP enzyme superfamily con-
sists of hundreds of enzymes grouped into numer-
ous families and sub-families according to their
genetic structures (http://drnelson.utmem.edu/
nelsonhomepage.html). Originally, the CYP en-
zymes were found in the mammalian liver, but
more recently they have also been found in other
mammalian tissues and in other animals, plants,
bacteria and fungi. In mammals, CYP-associated
activity has now been found in all tissues except
for skeletal muscle and erythrocytes (Guengerich
1993 a, b). The CYP enzymes involved in xeno-
biotic metabolism are mainly concentrated in the
liver and in those extrahepatic organs through
which foreign compounds pass when entering the
body, i.e. lung, skin and intestine, also referred to
as the body’s “first pass” protection (Raunio et al.
1995). The major CYP forms that metabolise for-
eign compounds belong to families CYP1, CYP2
and CYP3 (Nelson et al. 1996). Other CYP forms
catalyse the metabolism of steroids, fatty acids,
prostaglandins or lipophilic vitamins (reviewed
by Chang and Kam 1999). Over 200 000 chemi-
cals are thought to be metabolised by CYP en-
zymes. The various CYP forms also exhibit spe-
cies differences in substrate specificity. This spe-
cies difference is reflected in a variety of patterns
of contaminant accumulation and toxicological
effects among species. Thus, the well-documented
properties of CYP expression and activity in hu-
mans and laboratory animals (Boobis et al. 1990)
can only give a suggestion of the properties of the
various CYP enzymes and of their involvement
in xenobiotic metabolism in marine mammals.
The main characteristics of the CYP enzymes
chosen for the present study are summarised in
Table 1.
Despite the association of elevated frequen-
cies of pathological changes in marine mammals
with high levels of environmental contaminants,
surprisingly little is known of their xenobiotic
metabolising capacity. Putative members of the
CYP1A, CYP2B, CYP3A and CYP4A sub-fami-
lies have been found in some seal and whale spe-
cies (reviewed by Boon et al. 1992, Fossi et al.
1992, 1997, Murk et al. 1994, White et al. 1994,
Goksøyr 1995, Wolkers et al.1998, 1999). In true
seals, CYP-associated protein levels and activi-
ties have been reported in grey seals, harbour seals,
harp seals (Phoca groenlandica), hooded seals
(Cystophora cristata) and ringed seals (Englehardt
1982, Addison and Brodie 1984, Addison et al.
1986, Goksøyr et al. 1992, Goksøyr 1995, van
Hezik et al. 2001). The presence of CYP enzymes
and their substrate specificities have also been
suggested indirectly in marine mammals by study-
ing their contaminant profiles (Boon et al. 1987,
1994, Tanabe et al. 1988, Duinker et al. 1989,
Kannan et al. 1989, Bergek et al. 1992, Norstrom
et al. 1992, Bruhn et al. 1995, Letcher et al. 1998,
2000b). The biotransformation of individual com-
pounds has also been studied using in vitro as-
says of seal liver microsomes (Boon et al. 1998,
Kim et al. 1998, van Hezik et al. 2001).
1.5.2. Regulation of CYP enzymes
The regulation of the CYP proteins is governed
by both endogenous factors and foreign com-
pounds. CYP activity is influenced by a great
number of endogenous factors such as inflamma-
tion, diseases, stress, fasting, pregnancy, hormo-
nal signals, age, gender, and diurnal and seasonal
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rhythms (reviewed by Morgan et al. 1998, and by
Mugford and Kedders 1998). Dietary constituents
such as non-pro-vitamin A carotenoids induce
CYP1A activity, while vitamin A induces
CYP2A1and CYP3A2 but suppresses CYP1A1,
CYP2C8, CYP2C11 and CYP2C19 (Gradelet et
al. 1996, Ushio et al. 1996, Badger et al. 1998,
Yamazaki and Shiamada 1999, reviewed by
Ioannides 1999).
Xenobiotics can induce or inhibit CYP en-
zymes, or function as their substrates. Individual
chemicals can induce several different CYP forms
simultaneously. On the other hand many differ-
ent CYP forms use the same chemical as their
substrate. There is, however, a certain pattern for
the induction among the CYP enzymes in experi-
mental animals (reviewed by Hansen 1998). CYP
enzymes belonging to the CYP1A subfamily are
of particular interest to aquatic toxicologists be-
cause they are associated with the metabolism of
certain persistent and lipophilic environmental
pollutants in a wide range of species (Table 1).
Furthermore, PHAHs that bind to AhRs prima-
rily induce the enzyme subfamily CYP1A in a
number of species (Nebert and Gonzales 1987,
Safe 1994). The classic model for AhR-mediated
induction of CYP1 is summarised in Figure 2.
Lipophilic, planar PHAHs bind to the cytosolic
AhR, after which the complex binds to the AhR-
Nuclear-Translocator (ARNT). The new complex
is translocated to the nucleus and bound to the
xenobiotic responsive element (XRE) on the DNA.
This triggers the transcription of a battery of tar-
get genes, among others the cyp1A genes. The
CYP1A mRNA is translated to proteins in the
ribosomes and transported to the cytosolic endo-
plasmic reticulum (ER). The CYP1A enzymes
catabolise PHAHs to metabolites, which are fur-
ther metabolised and finally excreted from the
body. Under certain conditions, the metabolites
formed are more toxic than their parent com-
pounds, with detrimental consequences for the
Table 1. The most important xenobiotic metabolising CYP enzymes in human liver and their common substrates
and inducers.
—————————————————————————————————————————————————
CYP subfamily CYP proteins Substrates Inducers
—————————————————————————————————————————————————
CYP1A 1A1, 1A2 7-ethoxyresorufin, PAH, BNF, 3-MC, planar
PAH, planar PCBs, PCBs and PBBs, dioxins,
caffeine, estradiol furans
CYP1B 1B1 7-ethoxyresorufin, Presumably same
PAH, planar PCBs compounds as for CYP1A
CYP2A 2A6, 2A7 Coumarin, testosterone, PB, BNF, PCN, 3-
alkylnitrosamines MC, non-planar PCBs
CYP2B 2B6 Pentoxyresorufin, PB, PCN, non-planar
barbiturates, steroids PCBs, DDT and other
related pesticides
CYP2C 2C8, 2C9, 2C18, 2C19 Mephenytoin, PB
tolbutamide
CYP2D 2D6 Dextromethorphan, No known
various drugs
CYP2E 2E1 Alcohols, ketones, Alcohols, ketones,
hydrocarbons, starvation, diabetes
alkylnitrosamines
CYP3A 3A4, 3A5 Steroids, antibiotics and PCN, PB,
other drugs glucocorticoids
—————————————————————————————————————————————————
Compiled from Pelkonen and Bremier 1994, Stegeman and Hahn 1994, Lewis 1996, Pelkonen and Raunio
1997, Kim et al. 1998 and Lewis et al. 1998b. Substrates and inducers should be understood in relative terms,
as most compounds are metabolised by or induce more than one CYP isozyme.
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cell. The production of at least four other proteins
is also mediated through AhRs, but the synthesis
of CYP1A has been most intensively investigated
(reviewed by Nebert et al. 2000). Recently, alter-
native mechanisms to the AhR-dependent path-
way for the induction of CYP1A have been pro-
posed, especially in relation to its endogenous me-
tabolism (Gradelet et al. 1996, Guigal et al. 2000).
Although this endogenous metabolism has not yet
been elucidated, proposals put forward include an
involvement in cell cycle regulation, apoptosis and
the production of reactive oxygenated metabolite-
mediated oxidative stress (Nebert et al. 2000).
1.5.3. CYP enzymes as biomarkers
The xenobiotic metabolising capacity of CYP1A
enzymes seems to be well conserved through evo-
lution across a broad range of animal species
(Stegeman and Livingstone 1998). However, the
sensitivity, and the type and potency of response
to individual toxic compounds or mixtures vary
between species (Peakall 1992). The induction of
CYP1A through the activation of AhRs has been
used as a biomarker for exposure to dioxin-like
compounds in various aquatic organisms ranging
from mussels to fish, birds and mammals (re-
viewed by Peakall 1992, and by Stegeman and
Hahn 1994). It has also been proposed as a
biomarker for contaminant exposure in marine
mammals (Fossi et al. 1992, 1997, Goksøyr et al.
1992, White et al. 1994, Troisi and Mason 1997,
Marsili et al. 1998, Wolkers et al. 1998, 1999).
Of the other CYP forms involved in xenobiotic
metabolism, CYP1B1 is of interest because of its
capacity to metabolise and activate polycyclic
hydrocarbons, thereby often initiating carcinogen-
esis (Shimada et al. 1996, Baron et al. 1998, Kim
et al. 1998). An overlapping substrate specificity
together with antibody cross-reactions between
CYP1B1 and the two CYP1A forms in rodents
has made it difficult to distinguish between the
three members of the CYP1 family (Shimada et
al. 1998). CYP1B1 has not previously been docu-
mented in marine mammals, but is a potential
biomarker for PHAH exposure.
The CYP2 family is a diverse group of en-
zymes consisting of ten subfamilies (http://
drnelson.utmem.edu/nelsonhomepage.html).
Many of the CYP2A enzymes show a species
specificity in their constitutive activities and
substrate specificities, which suggests an evolu-
tionary adaptation to specific plant toxins in the
diet (Lewis 1996). The CYP2A, CYP2B and
CYP2C forms are induced by xenobiotics, espe-
cially by phenobarbital-like substances (Table 1).
On the other hand, CYP2E enzymes are induced
by low-molecular-weight aliphatic compounds, as
well as by fasting and diabetes. The CYP2D en-
zymes are not thought to be induced by
xenobiotics (Lewis 1996). Non-planar PCBs,
polybrominated biphenyls (PBBs), as well as pes-
ticides such as DDT, aldrin, endrin, heptachlor
and chlordane are metabolised by CYP2B en-
zymes (reviewed by Lewis 1996). As some of
these compounds are also inducers of CYP2B in
rats, CYP2B induction has been used as a marker
of exposure to non-planar organochlorines. In
addition to the CYP1 family, CYP2A, CYP2B,
CYP2E and CYP3A subfamilies are involved in
both detoxification and activation of toxic agents,
through the generation of ROS and through other
mechanisms not yet identified (Lewis 1996, Lewis
et al. 1998a). In terrestrial mammals, CYP3A
enzymes metabolise a large number of steroids
and exogenous compounds (Lewis 1996). The
CYP3A enzymes are the major drug-metabolis-
ing enzymes in humans, but are also induced by
xenobiotics, especially by phenobarbital-like com-
pounds (Okey 1990, You et al. 1999). Despite the
central role of the CYP3A enzymes in drug me-
tabolism, the reactions they catalyse have rarely
been used as biomarkers.
Because of the diverse effects of environmen-
tal exposure on the CYP enzymes it is essential to
have baseline knowledge of the species-specific
properties of these enzymes, and to use several
parallel methods when assessing their response
to contaminant exposure. A number of methods
have been developed to characterise and assess
different CYP forms in aquatic toxicology. The
most commonly used methods involve mRNA,
DNA, protein or catalytic activity (Goksøyr and
Förlin 1992, Nielsen et al. 1999). Most in vitro
assays developed for the assessment of environ-
mental exposure have focused on enzyme activ-
ity or protein concentration. CYP1A activity has
been most extensively analysed using the
ethoxyresorufin O-deethylase (EROD) or aryl
Biomarkers for exposure and effects of contamination in seals 19
hydrocarbon hydroxylase (AHH) assays (Goksøyr
and Förlin 1992). Pentoxyresorufin O-depentyl-
ation (PROD) has been most commonly used as
an exposure marker for CYP2B induction. To
further characterise the specific CYP forms,
chemical inhibitors have been used in the cata-
lytic assays. Protein levels have been determined
mainly by electrophoresis followed by immuno-
blotting. This method requires appropriate anti-
bodies for each CYP form which have been vali-
dated for the species studied. Both monoclonal
(MAb) and polyclonal (PAb) antibodies have been
used depending on their availability. In studies
on marine mammals, various kinds of antibodies
have been used, which have been raised against
human, rat or fish CYP proteins (Goksøyr and
Förlin 1992, Stegeman and Hahn 1994).
1.5.4. Chemical-activated luciferase expres-
sion (CALUX)
As an alternative to the CYP1A assays, a novel in
vitro assay has been developed to assess the total
internal toxic potency of dioxin-like compounds,
namely the chemical-activated luciferase gene
expression (CALUX) assay. It is based on a rat
hepatoma cell line into which a dioxin-respon-
sive element and the luciferase reporter gene of
the firefly (Photinus pyralis) have been incorpo-
rated (Aarts et al. 1995, Garrison et al. 1996). The
compounds in an environmental sample that bind
to the AhRs in the cells are quantified by the
luciferase activity. The luciferase response is con-
verted to TEF values and thereby quantified as a
summed CALUX-TEQ response (Murk 1997).
Sediment and tissues from fish and other wildlife
species have been assayed using the CALUX
method (Murk 1997, Murk et al. 1998).
1.6. Other biomarkers
1.6.1. Vitamins and hormones
In addition to the AhR-mediated toxicity, PCBs
and DDT interfere with the vitamin A homeostasis
in several different ways (Cecil et al. 1973,
Brouwer and van den Berg 1986, Brouwer et al.
1988, Chen et al. 1992, Murk 1997, Käkelä et al.
1999). Vitamin A is essential for reproduction,
foetal development and normal growth in mam-
mals. It is also required for vision, immune func-
tion and for the maintenance of differentiated epi-
thelia and mucus secretion. Vitamin A occurs in
many forms in the body, retinol being the active
form and retinyl esters the major storage forms
(Hendriks et al. 1985, Got et al. 1995). In marine
mammals, retinyl esters are mainly stored in
lipocytes in the liver and the blubber (Schweigert
et al. 1990a). The esters are hydrolysed to retinol
in the liver and transported in the blood bound to
retinol binding proteins (RBP). The plasma trans-
port system for vitamin A consists of a complex
of two proteins, transthyretin (TTR) and RBP
(Goodman 1984). Symptoms caused by PCB ex-
posure resemble those caused by vitamin A defi-
ciency (Blood et al. 1989). Experimental studies
on rodents have demonstrated that PCB
metabolites may interfere with the formation of
the RBP-TTR circulating complex by binding to
the TTR molecule. This results in a loss of plasma
retinol and the thyroid hormone thyroxin from the
circulation (Brouwer and van den Berg, 1986,
Brouwer et al. 1989). On the other hand, PCBs
may activate the release of retinol from the liver,
leading to increased plasma retinol levels and
depleted hepatic vitamin A stores (Brouwer et al.
1988, Spear et al. 1988, Chen et al. 1992, Murk
1997). Semi-field and field studies on wildlife
have reported reduced vitamin A concentrations
in contaminated animals, and have proposed this
as a biomarker for the toxic effects of PCBs
(Brouwer et al. 1989, reviewed by Peakall 1992,
Ross et al. 1994, Jenssen et al. 1995, Murk et al.
1998).
PCB exposure induces the production of free
radicals as by-products of oxidative metabolism
(Stegeman and Hahn 1994). Oxyradical produc-
tion generates oxidative stress that may, in turn,
lead to the initiation of carcinogenesis and vascu-
lar diseases (Stegeman et al. 1992, Toborek et al.
1995, Hennig et al. 1999). Being a major antioxi-
dant in the body, vitamin E protects unsaturated
fatty acids from degradation in cellular mem-
branes, as well as in plasma lipoproteins. In addi-
tion to its natural functions as a radical scaven-
ger, vitamin E protects against the oxidative stress
that PCBs cause in the endothelial cells (Slim et
al. 1999). Co-treatment with PCB and α-tocophe-
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rol (the main form of vitamin E in animals) in rats
inhibits lipid peroxidation caused by PCB
(Yamamoto et al. 1994). Elevated vitamin E con-
centrations as an adaptive response to oxidative
stress have been proposed as a biomarker for con-
taminant-induced oxygen radical production, al-
though it has received little attention (Stegeman
et al. 1992).
1.6.2. Haematological and clinical chemistry
parameters
The health status of humans, and of domestic and
captive animals, is generally assessed from a set
of routine diagnostic parameters in the blood, in-
cluding haematology and clinical chemistry. Dif-
ferential leukocyte counts reflect the immune and
infection status, and are used when screening for
toxic effects on the immune system. In studies on
both humans and rodents, PCB exposure most
commonly results in increased total serum lipids,
cholesterol and triglycerides (Allen et al. 1976,
Kreiss et al. 1981, Borlakoglu and Welch 1992,
Yamamoto et al. 1994). Elevated serum lipids
indicate an accumulation of lipids in the liver,
which may lead to hepato-pathological changes
(Vandenberghe 1996). In experimental animals,
alanine aminotransferase (ALAT), aspartate ami-
notransferase (ASAT), alkaline phosphatase
(AFOS) and lactate dehydrogenase (LD) are af-
fected by a number of environmental pollutants
in vitro, but the corresponding effect has been
difficult to demonstrate in vivo (reviewed by
Christensen et al. 1982).
Clinical screening parameters have been in-
vestigated in environmental studies as potential
biomarkers mostly in birds and fish. Elevated
ASAT, ALAT and LD levels have been observed
in various species environmentally exposed to
PHAHs, organophosphates, carbamates, metals
and oil (reviewed by Peakall 1992). The increase
in the levels probably reflects general tissue dam-
age, especially in the case of ALAT in the liver.
Effects of contaminant exposure on AFOS are
variable, depending on the type of compound and
on the species (Peakall 1992). Very few studies
on marine mammals have included clinical blood
parameters as indicators of contaminant exposure.
Captive harbour seals that had been fed contami-
nated fish from the Baltic Sea showed increased
haematocrit, erythrocyte and granulocyte levels,
but no clear toxic effects were detected in the clini-
cal chemistry values (De Swart et al. 1994, 1995).
2. Aims and outline of the thesis
In this study, a large variety of biochemical pa-
rameters were tested for use as biomarkers for the
exposure and toxic effects of the PHAH load in
seals. We then used these biomarkers to investi-
gate whether ringed and grey seals are exposed to
and possibly affected by the PHAH load in the
Baltic Sea. We chose biochemical parameters that
have been affected by PHAH exposure in experi-
mental animals and other wildlife species. Fur-
thermore, we included biochemical parameters
that describe the general health status of the seals.
The thesis is divided into two parts:
1. Screening of methods for characterising po-
tential biomarkers in ringed and grey seals
2. Application of the chosen parameters
The first part is addressed in papers I–V. The
sampling methods were adapted to the conditions
during sampling, transport and storage. All labo-
ratory methods were tested and optimised for seal
tissue. One of the most commonly used exposure
biomarkers, CYP1A was determined in the Bal-
tic and Svalbard ringed seals, both at the enzymatic
activity and the protein level (I). The CYP1 fam-
ily was further characterised in ringed and grey
seals using additional methods (II). The cellular
distribution and activity pattern of CYP1A was
determined in various tissues to characterise which
organs are primarily exposed to xenobiotics (III).
The characterisation of the seal CYP enzymes was
expanded to include members of the CYP2 and
CYP3 families, based on what is known about
xenobiotic metabolism in humans and rodents
(IV). Vitamins A and E, and haematological and
clinical chemistry parameters were analysed in
ringed and grey seals from the Baltic Sea and from
reference areas in order to establish baseline val-
ues for these parameters and to search for poten-
tial biomarkers (V).
The second part of the thesis investigates
whether the Baltic seals are affected by the con-
taminant load and discusses the applicability of
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the potential biomarkers in this case study (VI).
Furthermore, we consider whether the two spe-
cies differ in terms of susceptibility to the con-
taminant load, and of metabolising capacity.
3. Material and methods
3.1. Animals
Grey seals living in the waters around Sable Is-
land, Canada, and ringed seals from the European
Arctic (Svalbard) were used as reference animals
in this thesis as these seals have not had the same
degree of exposure to PHAHs as the Baltic seals.
The average sum PCB and DDT levels in these
seals are 0.4–8 mg/kg lipid, which is one third to
one hundredth of the levels in the Baltic seals (Fig-
ure 3). The Sable Island grey seals differ from
their Baltic relatives by having a slightly larger
body size and by slightly earlier breeding and
pupping seasons. Svalbard ringed seals have a
similar size to their Baltic cousins but have a
slightly later pupping, breeding and moulting sea-
son. We aimed always to collect samples during
approximately the same phase of the moulting
season of each seal population.
Sample collection, storage and preparation is
described in detail elsewhere (I, V, Fant et al. 2001,
VI). As the CYP activity is not homogeneously
distributed in the liver, samples were taken from
four different parts of each liver and mixed
(Oinonen 1996). Sera and plasma collected for
the vitamin and clinical chemistry analyses were
separated in the field. All samples for the bio-
chemical assays were stored in liquid nitrogen
during field work and transportation, and at –70 °C
in the laboratory until analysis. The vitamin sam-
ples were packed in aluminium foil to protect them
from light.
Age was determined by counting the annual
layers of the cementum in the canine tooth (Laws
1952). An index of condition was determined by
dividing the blubber thickness by the body length.
The condition index was modified from the meth-
ods developed by Read (1990) and Beck and Smith
(1995). No geographical differences in the condi-
tion index were observed between the respective
seal population (V). Although the Sable Island
grey seals were slightly older than the Baltic popu-
lation (p < 0.01), the age ranges were similar. Of
all the biochemical parameters assayed, only the
calcium level in grey seals was dependent on age.
3.2. CYP assays
Microsome preparation and the enzyme assays
have been described in detail elsewhere (I, III,
IV). The enzyme activity assays are summarised
in Table 2. In short, microsomes were separated
by two successive centrifugations (10 000 g × 30
min and 100 000 g × 60 min). EROD, PROD and
coumarin 7-hydroxylase (COH) activities were as-
Figure 3. Concentrations of (A) sum PCB, sum DDT
and (B) trace elements in the liver of ringed and grey
seals from different geographical locations. Results
are presented as individual points and as means ± SD
(horizontal bar ± vertical bars). Statistically significant
geographical differences are marked with asterisks (*p
< 0.05, **p < 0.01, ***p < 0.001).
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sayed using fluorometric end-point assays (Burke
et al. 1977, Aitio 1978). S-mephenytoin 4´-
hydroxylation (Wrighton et al. 1993), dextrameth-
orphan O-demethylation (DOM, Park et al. 1984,
Kronbach et al. 1987) and chlorozoxazone 6-
hydroxylation (C-6-OH, Peter et al.1990) were
analysed using high-performance liquid chromato-
graphy (HPLC). Testosterone 6β-hydroxylation
(TEBH) was assayed using thin layer chromatog-
raphy (Waxman et al. 1983). Hepatic CYP activi-
ties were determined from individual samples,
whereas extrahepatic samples were pooled from
four individuals according to gender, species and
location. Protein concentrations were determined
according to Bradford (1976). The EROD and
COH assays were optimised both for protein and
substrate concentrations prior to the inhibition
studies (II, IV). Specific CYP inhibitors and anti-
bodies were used in the enzyme inhibition stud-
ies. Detailed descriptions of the use of the inhibi-
tors have been presented previously (I, II, IV).
The inhibitors are summarised in Table 2.
Relative protein concentrations of the various
CYP enzymes were determined from individual
microsomal liver samples using SDS-PAGE and
immunoblot analysis (I). The microsomes were
separated in polyacrylamide gel by electrophore-
sis and transferred to nitrocellulose filters accord-
ing to the method of Towbin et al. (1979). The
filters were blocked with 4% fat-free milk pow-
der and incubated overnight with the primary an-
tibody at 4 °C. The antibodies and positive con-
trols used are presented in Table 3. The filters were
treated with the horseradish peroxidase-conju-
gated secondary antibody, and the proteins were
visualised using the ECL or ECL+ method
(Amersham). Relative quantification was con-
ducted on the protein bands from individual seals
Table 2. Methods used for determining protein, CYP activity and vitamin levels.
—————————————————————————————————————————————————
Assay Parameter Method Standards or Inhibitors
positive controls
—————————————————————————————————————————————————
Total protein Protein Spectro-photometric Bovine serum
determination albumin
Ethoxyresorufin CYP1A Fluorometric Ethoxyresorufin α-Naphthoflavone
O-deethylation Furafylline
Coumarin-7- CYP2A Fluorometric 7-ethoxycoumarin α-Naphthoflavone
hydroxylation Methoxsalen
Anti-mouse CYP2A5a
Pentoxyresorufin CYP2B Fluorometric Pentoxyresorufin α-Naphthoflavone
O-deethylation Furafylline
S-Mephenytoin CYP2C HPLC Human liver
4´-hydroxylation
Dextromethorphan CYP2D HPLC Human liver α-Naphthoflavone
O-demethylation
Chlorzoxazone CYP2E HPLC Human liver Pyridine
6-hydroxylation α-Naphthoflavone
Testosterone CYP3A TLC Human liver Ketoconazole
6β- hydroxylation
Retinol and Vitamin A HPLC Retinyl acetate
retinyl palmitate
α-Tocopherol Vitamin E HPLC 5,7-dimethyltocol
—————————————————————————————————————————————————
HPLC, high-performance liquid chromatography
TLC, thin layer chromatography
a Polyclonal (Raunio et al. 1998)
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using the Image Master VDS gel analysis system
and software (Amersham, Pharmacia).
Immunohistochemical analyses were per-
formed using monoclonal antibody (MAb 1-12-
3) against scup P450E which corresponds to mam-
malian CYP1A (III). An indirect peroxidase la-
belling method for immunohistochemical stain-
ing was used (Myers et al. 1994). A relative stain-
ing index was used to quantify the tissue sections
(III).
3.3. CALUX
To assess the internal toxic potency of dioxin-re-
lated compounds in the seals, liver extracts form
ringed or grey seals were added to the CALUX in
vitro assay. Extraction of liver samples and the
CALUX assay has been described in paper VI. A
rat hepatoma cell line, with an incorporated di-
oxin-responsive element and a luciferase reporter
gene, were incubated with the liver extracts for
24 h. The luciferase activity was determined di-
rectly from the cultivation plates by luminometer.
The luciferase response was converted to
CALUX-TEQ-values by interpolation from a
TCDD standard curve.
3.4. Vitamins A and E
Sampling, extraction and analysis of vitamins has
been reported in detail in paper V. Liver, blubber
and plasma samples were used to determine vita-
mins A and E. The extraction method was modi-
fied from Murk et al. (1998). Vitamins were ana-
lysed by HPLC using a reversed-phase column
and isocratic conditions (Table 2). The vitamins
detected in seal tissues were vitamin A (retinol
and retinyl palmitate) and vitamin E (α-tocophe-
rol). Retinylpalmitate was the dominating form
of vitamin A in liver and blubber (88–99% of the
Table 3. Polyclonal and monoclonal antibodies for different CYP enzymes
—————————————————————————————————————————————————
CYP forms Antibody Positive control
—————————————————————————————————————————————————
CYP1A MAb 1-7-1a TCDD-treated rat
Anti-human CYP1A1b
Anti-human CYP1A2b
MAb 1-12-3c
CYP1B Anti-mouse CYP1B1b TCDD-treated rat
CYP2A Anti-mouse CYP2A5d Purified mouse liver CYP2A5
Anti-human CYP2A6e
CYP2B Anti-rat CYP2B1f Phenobarbital-treated rat
Anti-rat CYP2B1e
Anti-human CYP2B6b
MAb 2-66-3a
CYP2C MAb 1-68-11a Phenobarbital-treated rat
CYP2E MAb 1-98-1a Acetone-treated mouse
CYP3A MAb 2-13-1a
Anti-human CYP3A4b Expressed human CYP3A4g
Phenobarbital-treated rat
—————————————————————————————————————————————————
Reference to antibodies:
a Monoclonal (Dr. H. Gelboin, National Cancer Institute, Bethesda, MD, USA)
b Polyclonal anti-peptide (Dr. A. Boobis, Imperial College School of Medicine, London, UK)
c monoclonal (Dr. J. Stegeman, Woods Hole Oceanographic Institution, USA and Dr. H. Gelboin, National
Cancer Institute, Bethesda, MD, USA)
d Polyclonal (Raunio et al. 1998)
e Monoclonal (Gentest, Woburn, MA, USA)
f Monoclonal (Oxford Medical Research, UK)
g
 Baculovirus-expressed microsomes (Gentest, Woburn, MA, USA)
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total vitamin A content). In plasma, only retinol
was detected.
3.5. Haematology and clinical chemistry
Specific sampling methods were developed for
the haematological samples. For blood cell deter-
mination, erythrocytes and leukocytes were fixed
in glutaraldehyde solutions in the field and stored
at room temperature until analysis. Differential
leukocyte counts were determined from May-
Grynwald-Giemsa stained blood smears (Dacie
and Lewis 1984). Haematocrit was determined di-
rectly in the field with a haematocrit centrifuge.
Blood samples were mixed with haemoglobin rea-
gent and stored at room temperature, protected
from light, until analysed using spectrophotom-
etry (Nuutinen 1972). The 26 clinical chemistry
parameters were determined from frozen serum
using automatic analyser in Yhtyneet Laboratoriot
Oy.
4. Results and discussion
A basic understanding of a biological parameter
and the method of its analysis are needed before
it can be investigated as a potential bioindicator
in wild animals. Therefore, a large part of this
thesis deals with the search for appropriate pa-
rameters that can be assayed in seal samples that
have been collected in the field. Then, particular
biomarkers were evaluated, based on their expres-
sion pattern and correlation to the individual PCB,
DDT and heavy metal load, for their applicability
to study the exposure and toxicity in the seal
populations. The results of the main findings are
presented and discussed separately.
4.1. Presence of the CYP1 family in ringed
and grey seals
CYP1A has shown little genetic variation and
there are great similarities with respect to substrate
and inducer specificity across species (Stegeman
and Livingstone 1998). However, as all marker
assays for CYP1A have been developed for use
on human and rodent samples, it is not self-evi-
dent that they are specific for CYP1A in other
species using the same methods. Enzymatic as-
says, specific enzyme inhibitors, kinetic models
and immunoblotting analysis were, therefore, used
in parallel to ensure a broad assessment of CYP1A
in seals.
Both ringed and grey seals from the reference
areas showed hepatic EROD activities that were
in the same range or slightly higher than those
found in livers of other marine mammals, un-
treated rats and humans (I, II, III, reviewed by
Boon et al. 1992, White et al. 1994, Goksøyr 1995,
Fossi et al. 1997, Wolkers et al. 1998, 1999,
Weaver et al. 1999). Both the kinetic properties
of EROD activity in the seals and the inhibition
patterns, caused by low concentrations of CYP1A-
specific inhibitors (α-naphthoflavone, furafylline),
suggest that CYP1A mediates EROD activity at
both low and elevated levels. This is contrary to
the situation in rats, in which constitutive EROD
activity is mediated by several different CYP
forms (II). Consistent with these results, EROD
activity was potently inhibited with a monoclonal
antibody against rat CYP1A1 (MAb1-7-1). It is
possible that the seals possess both CYP1A1 and
CYP1A2 forms, but more detailed studies are
needed to clarify this question. Other studies have
indicated that either CYP1A1 alone or both
CYP1A forms are present on marine mammals
(Watanabe et al. 1989, Goksøyr et al. 1992,
Wolkers et al. 1998, 1999).
In addition to the CYP1A subfamily, we in-
vestigated the expression of CYP1B1 in ringed
and grey seals. A protein band was revealed in
the seals with a molecular weight corresponding
to the human CYP1B1, but there was no indica-
tion of an elevation of CYP1B1 expression in the
Baltic seals (II). This suggests that a putative
CYP1B1 enzyme is present in ringed and grey
seals, but that the PHAH load in the Baltic seals
does not stimulate CYP1B1 expression.
4.2. Elevated CYP1A expression in the
heavily polluted Baltic seal populations
There is a vast literature on CYP1A induction as a
bioindicator for PHAH exposure in wildlife. How-
ever, individual PCBs and higher doses PHAHs
have been reported to decrease CYP1A enzyme
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activity in both experimental and field studies
(Gooch et al. 1989, Sinclair et al. 1989, Huuskonen
and Lindström-Seppä 1995, Schlezinger et al.
1999). When conducting a study on free ranging
animals it is important to be aware of possible in-
ternal and external factors that may influence the
CYP activity and protein levels. To minimise the
differences in CYP expression due to factors other
than the contaminant load, all seals in this study
were sampled during their moulting season. Dur-
ing this time, both ringed and grey seals reduce
their food intake and use their fat reserves as an
energy source. The lipophilic contaminants that
have accumulated in the blubber are released as
the fat content is reduced. The seals are, therefore,
most vulnerable to the toxic effects of their pollut-
ant load during the moulting season.
Both EROD activity and CYP1A protein lev-
els in the liver were clearly higher in both Baltic
seal populations than in their respective reference
seal populations (I, II, Figure 4). The EROD ac-
tivity in the Baltic seals reached levels similar to
TCDD-treated rats. Since TCDD is the most po-
tent CYP1A inducer in the rat, the high level of
EROD in the Baltic seals is worth attention.
Svalbard ringed seals showed a higher EROD
activity than Sable Island grey seals (p < 0.001,
II), suggesting either a higher constitutive CYP1A
expression in ringed seals, or that Arctic ringed
seals are exposed to CYP1A-inducing compounds
not identified in this study. On the other hand, the
geographical difference was greater in the grey
seals (Figure 4), which could reflect a greater sen-
sitivity to CYP1A inducing agents in grey seals.
As the two species differed in many aspects, the
species differences are discussed in more detail
later.
After entering the seal, PHAHs are distributed
with the blood flow mainly to the liver, but also
to other organs. To study the possible effects of
the contaminant load on the whole organism, we
examined CYP1A in a number of extrahepatic tis-
sues using EROD assay, immunoblotting and
immunohistochemical analyses. CYP1A activity
was found in most of the tissues studied, with the
highest activities in the lung, kidneys, adrenal
glands and heart (III). Extrahepatic CYP activi-
ties were at least one order of magnitude lower
than in the liver, but at similar levels to those re-
ported for untreated rats (Jewell and O’Brien
1999). High CYP1A protein and activity levels
were found in most tissues of both species of Bal-
tic seal compared to the reference populations (III).
No extrahepatic CYP1A expression was revealed
in the immunoblot analyses. This suggests that
immunoblotting is not as sensitive as immuno-
histochemistry or enzyme activity assays. A spe-
cies difference similar to the one seen in the liver
was also observed in extrahepatic tissues in gen-
eral. Baltic ringed seals showed the highest
CYP1A expression followed by the Baltic grey
seals and the reference seals. Most commonly,
Figure 4. Activity profiles
of putative CYP forms af-
ter calculating the relative
CYP activity in the Baltic
seal population with re-
spect to the reference seal
population. Relative CYP
activities are calculated
from the results of assays
for CYP1A (EROD), CYP2B
(PROD), CYP2D (DOM),
CYP2E (C-6-OH), CYP2A
(COH) and CYP3A (TEBH).
Statistically significant geo-
graphical differences are
marked with asterisks (*p
< 0.05, **p < 0.01, ***p <
0.001). The number (n) of
seals used in each assay
is marked below the figure.
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CYP1A expression was observed in the endothe-
lial cells of the blood vessels in all tissues except
for the liver in which the hepatocytes showed the
highest CYP1A expression. This is consistent with
the CYP1A induction pattern in experimental ani-
mals after treatment with CYP1A inducers (Dees
et al. 1982, Anderson et al. 1987, Stegeman et al.
1989, Thirman et al. 1994). The CYP1A expres-
sion in the blood vessel walls may be followed by
oxidative stress, which in turn may alter endog-
enous functions throughout the circulatory system.
To summarise, both CYP1A and CYP1B are
probably present in ringed and grey seals. The
hepatic and extrahepatic CYP1A expressions are
clearly higher in the Baltic seal populations than
in the reference populations. This elevated CYP1A
expression suggests that the Baltic seals are ex-
posed to dioxin-like compounds that might affect
the whole body.
4.3. Characterisation of other CYP forms
in Baltic seals
Contrary to the CYP1A subfamily, many of the
other xenobiotic-metabolising CYP enzymes vary
greatly between species both in terms of substrate
and inducer /inhibitor specificity. In this study,
we characterised the profile of putative members
of CYP2A, CYP2B, CYP2C, CYP2D, CYP2E
and CYP3A subfamilies in both species, and tested
the available assays for their applicability to seal
tissues (Table 2).
CYP2A-like activity (COH) was high in the
liver and lungs of all four seal populations, and
showed a sexual dimorphism, with higher values
in females than in males (IV). COH was strongly
inhibited by a chemical inhibitor or by an anti-
CYP2A5 antibody, which suggests the presence
of a putative CYP2A form in these seals. This
putative CYP2A profile with a sexual dimorphism
and a high level of activity in the lungs, resem-
bles that of rodents (Honkakoski et al. 1993, Lewis
and Lake 1995). The lack of geographical varia-
tion is surprising, as CYP2A is known to be in-
duced by substances that act like phenobarbital,
such as DDT (Figure 4) (Parkinson et al. 1983,
Pelkonen et al. 1997).
CYP2B has been used as an exposure
biomarker for non-planar PCBs that induce
CYP2B expression, although the mechanism is
not known (reviewed by Peakall 1992). Using
PROD as the CYP2B-associated enzyme assay,
no induction was reported in fish exposed to typi-
cal CYP2B inducers (Stegeman and Hahn 1994).
The function of PROD as a CYP2B biomarker
has also been critically discussed with respect to
marine mammals. Even the presence of CYP2B
in marine mammals has been debated. Based on
the PCB patterns in marine mammals compared
to the patterns in their main prey species, it has
been suggested that marine mammals lack CYP2B
activity (Tanabe et al. 1988, Norstrom et al. 1992).
Low PROD activity has been found in different
marine mammal species (Goksøyr et al. 1992,
White et al. 1994, Fossi et al. 1997, Wolkers et al.
1998). However, our studies suggest that PROD
activity is associated with CYP1A rather than with
CYP2B in both ringed and grey seals (I, II). A
strong correlation between individual EROD and
PROD levels, together with a strong inhibition of
PROD using CYP1A-specific antibodies support
our proposal. Furthermore, none of the four dif-
ferent CYP2B-specific antibodies used in the
immunoblot analyses showed any binding with
either ringed seal or grey seal liver microsomes
(IV). Other studies have succeeded in showing
the presence of proteins in marine mammals of a
corresponding molecular weight to rodent CYP2B
using antibodies against dog, rabbit or rat CYP2B
(Goksøyr et al. 1992, Stegeman and Hahn 1994,
Goksøyr 1995, Wolkers et al. 1998, 1999, van
Hezik et al. 2001). Yet, several others have failed
to demonstrate the presence of CYP2B using anti-
rat antibodies (Goksøyr et al. 1988, White et al.
1994, Stegeman and Hahn 1994). A strong corre-
lation between CYP1A and PROD has also been
observed in other wildlife species, suggesting that
CYP1A and not CYP2B is the primary catalyst in
PROD (White et al. 1994, Bosveld et al. 1995,
Van der Oost et al. 1996, Letcher et al. 1996,
Wolkers et al. 1998, Lange et al. 1999). The pres-
ence or absence of CYP2B in the seal species stud-
ied can only be confirmed by cDNA cloning and/
or protein purification. However, variation in
PROD activity does not seem to be a valid
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biomarker for non-dioxin-like PHAH exposure in
ringed or grey seals.
Antibodies against human and rodent CYP2C
and CYP2E forms did not recognise any proteins
in the seal species studied. Neither did S-
mephenytoin 4´-hydroxylation, a marker for
CYP2C in human liver, show any activity in seal
liver (IV). Activities of putative CYP2D (DOM)
and CYP2E (C-6-OH) were measurable in the seal
livers, and were higher in the Baltic seals than in
the reference seals (Figure 4). Both activities
showed a strong positive correlation with CYP1A
activity and were inhibited by a CYP1A inhibitor
(IV). Both the inhibition profile and the fact that
CYP2D is not induced by xenobiotics in other
species, suggest that DOM is rather associated
with CYP1A activity in these seals. C-6-OH is a
substrate for both CYP2E and CYP1A in human
liver (Carriere et al. 1993, Ono et al. 1995). The
strong positive correlation between C-6-OH and
both DOM and EROD indicate that C-6-OH is
mediated, at least partly, by CYP1A in ringed and
grey seals. However, the inhibition of C-6-OH
using a relatively specific CYP2E inhibitor, to-
gether with reports of putative CYP2E findings
in other marine mammals, point to the presence
of a member of the CYP2E subfamily in these
seals. DOM and C-6-OH cannot, therefore, be
proposed as marker assays for CYP2D and
CYP2E activities in these seal species.
The presence of a CYP3A–like protein in the
seal species studied is supported by relatively high
levels of testosterone 6β-hydroxylation (TEBH),
a CYP3A marker (IV). Further, TEBH was po-
tently inhibited by a selective inhibitor of CYP3A
(ketoconazole), and CYP3A protein levels showed
a positive correlation with TEBH. The putative
CYP3A activity showed a reverse geographical
trend to that of CYP1A, with a lower expression
in the Baltic seals (Figure 4). This is surprising as
CYP3A is known to be induced by phenobarbi-
tal-like compounds such as DDT (Okey 1990, You
et al. 1999). The reasons for the reduction are un-
known.
As a summary, putative CYP2A and CYP3A
enzymes are expressed in ringed and grey seals,
but CYP2B and CYP2C enzymes are not. Further
studies are needed to determine the presence and
characteristics of CYP2D and CYP2E enzymes
in ringed and grey seals.
4.4. Elevated CALUX-response in the Bal-
tic seals
The CALUX-response was clearly higher in the
Baltic ringed seals than in the Svalbard ringed
seals, but only slightly higher than the Baltic grey
seals (VI). Individual CALUX-TEQ values cor-
related positively with ∑PCB-TEQ, and with both
∑PCB and ∑DDT. This suggests that the DDTs
and non-planar PCBs co-accumulate with the pla-
nar PCBs. The lack of correlation between the
CALUX-response and any of the biochemical
parameters is contradictory to reports in birds and
otters (Murk 1997, Murk et al. 1998). This could
be due to the very high burdens of dioxin-like
compounds, at which the correlative relationship
levels off. Although the CALUX assay has been
developed as a bioindicator of exposure to dioxin-
like substances, it apparently reflects the whole
PCB and DDT burden in ringed seals in this par-
ticular situation.
4.5. Characterisation of other biochemi-
cal parameters
The species-specific characteristics and the geo-
graphical trends in the levels of vitamins A and E
as well as clinical blood parameters were deter-
mined in ringed and grey seals (V).
4.5.1. Vitamins A and E
Vitamin A and E levels in the reference seal
populations were in the same range as previously
reported for grey seals and other pinnipeds
(Schweigert et al. 1987, 1990a, 1990b). Vitamin
E levels, measured in liver, plasma and blubber,
were clearly higher in both Baltic seal populations
than in their respective reference populations (V).
On the contrary, total vitamin A concentrations
in liver and blubber were lower in the Baltic grey
seals (V). The same trend was also seen in the
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liver of ringed seals. The diverging vitamin lev-
els in the Baltic seals could be caused by different
levels of dietary vitamins in the seal populations,
or by toxic effects of the contaminant load in the
Baltic seals. As vitamin A and E concentrations
in fish species are highly variable, a careful com-
parison of the vitamin contents of the main food
sources for each seal population might clarify the
impact of the food source on the vitamin status. A
paucity of information about the vitamin content
in whole prey organisms makes this comparison
impossible at present.
4.5.2. Clinical parameters
Both haematological and clinical chemistry pa-
rameters were in general within the ranges of those
reported for wild and captive phocids (Greenwood
1971, Engelhardt 1979, Geraci et al. 1979,
McConnell and Vaughan 1983, De Swart et al.
1995). We observed no clear species or geographi-
cal differences in haematological or clinical chem-
istry parameters, probably due to large individual
variations in many of the parameters. Slightly el-
evated albumin and AFOS levels, and reduced
urea levels in both Baltic populations were noted.
In grey seals, slightly elevated phosphorus and
calcium, and reduced chloride concentrations were
observed in the Baltic seals, while no correspond-
ing differences were seen between the two ringed
seal populations. The difference in calcium lev-
els was clearly affected by the geographical dif-
ference in age between the two grey seal
populations (tested with ANOVA). Although the
geographically diverging blood parameters were
all within range of those reported for other phocids,
this does no necessarily mean that these values
are normal for ringed or grey seals. Pathological
investigations are needed to better understand the
observed variations in blood parameters.
4.6 The PHAH and heavy metal load in the
Baltic seals
When searching for biomarkers of chemical ex-
posure and effect, it is essential to obtain infor-
mation about the individual contaminant load.
Although the contaminant analyses are not a cen-
tral part of this thesis, the results serve as a basis
for the search for potential biomarkers. The lev-
els of a total of 34 PCB congeners and both o,p´-
and p,p´-isomers of DDT, DDE and DDD were
determined (VI). In addition, mercury, cadmium,
lead and selenium levels were determined in vari-
ous tissues (Fant et al. 2001, VI). A summary of
the observed contaminant burdens in liver and the
geographical variations are presented in Figure 3.
Average ∑PCB and ∑DDT levels were higher in
the Baltic seals than in the seals from the refer-
ence areas (p < 0.001 for both contaminants in
both species). On the other hand, cadmium levels
were four to six times higher in the reference seals
(IV). Mercury and selenium levels were higher in
the Baltic ringed seals than in the Svalbard ringed
seals. In the Baltic seals, mean ∑PCB levels were
twice as high as ∑DDT levels and both PHAHs
were clearly higher in ringed seals than in grey
seals. ∑DDTs showed a strong positive correla-
tion with ∑PCB in both species (VI). Similarly,
mercury correlated with selenium in all seal
populations (data not shown). A difference be-
tween gender was only observed in the grey seals,
where females had higher cadmium levels (Fig-
ure 3). On Sable Island, males had higher ∑DDT
and ∑PCB levels than the females (Figure 3). Both
∑DDT and ∑PCB were age-dependent in the
Baltic ringed seal males, while an age depend-
ency was seen only for ∑DDT in the Baltic fe-
males and in the Svalbard males, and for ∑PCB
in Sable Island grey seal males (VI). Mercury and
selenium were age dependent in all seal
populations except for the Baltic ringed seals.
Studies on contaminant patterns of the exposed
animals give indirect information about the ani-
mals’ susceptibility to contaminants and about
their metabolic capacity. These methods have been
used especially to characterise the CYP system in
marine mammals, as it is difficult to obtain ap-
propriate tissues for CYP assays (Boon et al. 1987,
1994, Tanabe et al. 1988, Duinker et al. 1989,
Kannan et al. 1989, Bergek et al. 1992, Norstrom
et al. 1992, Bruhn et al. 1995, Letcher et al. 1998,
2000b). The contaminant profile of the Baltic seal
populations is only discussed in short.
The obvious differences in the levels of PCB
and DDT contamination in both Baltic seal spe-
cies have been explained by a more rapid decrease
of DDT in the environment since it was banned in
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the 1970s (Bignert et al. 1998). On the other hand,
PCBs are still continuously released into the en-
vironment, and the levels are even expected to
increase with time (Jonsson et al. 1996, Bignert
et al. 1998). The clearly higher mean ∑PCB and
∑DDT burden in the Baltic ringed seals compared
to grey seals could be caused by differences in
diet and feeding activity, and/or species-specific
physical (body size) and physiological (metabolic
capacity) characteristics. The accumulation pat-
tern for the DDT compounds differed between
ringed and grey seals (Jaana Koistinen, unpub-
lished). The proportion of the parent compound
in the total DDT burden was much higher in the
grey seals than in the ringed seals. This suggests
that the ringed seals metabolise DDT more effi-
ciently, which could be the result of CYP induc-
tion caused by the clearly higher PCB and DDT
burden.
A comparison of the PCB profile between the
Baltic seals and their respective reference
populations showed a relatively high proportion
of the lower chlorinated congeners in the refer-
ence areas, while the more persistent congeners
were more prominent in the Baltic populations.
As the less chlorinated congeners are more easily
metabolised, this pattern may suggest an induced
CYP activity in the Baltic seals. The proportion
of the mono-ortho and di-ortho PCBs was clearly
higher in the reference ringed seals compared to
the Baltic population, while no corresponding dif-
ference was observed between the grey seal
populations. The findings in ringed seals are con-
sistent with reports on contaminant patterns in this
species by Norstrom and Muir (1994), who pro-
posed that the increased capacity of the Baltic seals
to metabolise xenobiotic compounds could be due
to an induction of CYP1A expression. As the main
PCB intake in seals is through the diet, any vari-
ation in the dietary PCB profile is of interest.
However, it has been stated that PCB levels in
arthropods and fish are very similar because they
are controlled by the ambient concentrations in
the water (Tanabe 1988).
The levels of cadmium and lead in the seals
studied were below reported effect threshold lev-
els in marine mammals (AMAP 1998). Although
many seals from the Baltic Sea and Canadian
waters showed hepatic mercury concentrations
exceeding the threshold levels, no signs of mer-
cury intoxication were observed (Fant et al. 2001,
Jaana Koistinen unpublished). There are several
other examples of very high concentrations of
mercury in the livers of marine mammals, with-
out evidence of toxic effects (reviewed by O’Shea
1999). It has been suggested that marine mam-
mals have evolved biochemical mechanisms to
tolerate high exposure to mercury by forming
stabile mercury-selenium complexes, which are
stored mainly in the liver without apparent harm
(reviewed by Cuvin-Aralar and Furness 1991).
4.7. Choice of potential biomarkers
The possibility of using any of the biochemical
parameters as biomarkers was evaluated by first
choosing those parameters that had shown a geo-
graphical difference between the Baltic and the
reference populations. These parameters were then
correlated with representatives of planar and non-
planar PCBs (CB126 and CB153, respectively),
with ∑DDT and with metals using Pearson’s cor-
relation analysis. Statistical significance was set
at p < 0.05. The network of relationships revealed
both general and species-specific characteristics
(Figure 5). Both PCBs and ∑DDT correlated posi-
tively with EROD and vitamin E (especially in
plasma) in both species. In ringed seals, CALUX
and AFOS showed a positive relationship with
the organic contaminants, while the relationship
was the reverse for ASAT. Furthermore, albumin
showed a positive correlation with mercury and
selenium, while the correlation between the met-
als and LDL and ASAT were negative. In grey
seals, phosphorus, calcium and uric acid were
positively correlated with the organic contami-
nants, while chloride and urea showed a negative
correlation. The correlation between the vitamin
A parameters and the contaminants was not con-
sistent. The presence of retinol in plasma corre-
lated positively with the organic contaminants,
while retinyl palmitate in blubber and liver corre-
lated negatively with the planar PCBs. In gen-
eral, cadmium levels showed the reverse relation-
ship with the biochemical parameters to that ob-
served for the organic pollutants. The observed
network of relationships should be interpreted with
caution as the complexity of patterns makes it
difficult to discern the direct connections between
Nyman30
parameters and contaminants from the indirect
ones.
The strong positive correlation between EROD
and the DDT and PCB compounds in both spe-
cies suggests either an induction of CYP1A by all
these compounds, or merely a reflection of the co-
accumulation of organic contaminants (VI). The
former proposal is supported by the high induc-
tion of EROD in rats treated with phenobarbital (a
compound with characteristics similar to the DDTs
and non-planar PCBs), indicating that EROD is
not strictly associated with CYP1A (II). Neither
putative CYP2A nor CYP3A expression showed
any correlation with individual xenobiotic loads.
A strong positive correlation between vitamin
E levels and both PCBs and ∑DDT supports the
hypothesis that the higher level of vitamin E in
the Baltic seals is a response to oxidative stress
caused by the contaminant load. Furthermore, this
trend was more obvious in ringed seals suffering
from a higher contaminant load. Mercury and
cadmium are known to induce lipid peroxidation
and radical production (Stacey and Kappus 1982,
Manca et al. 1991). The antioxidising function of
vitamin E could explain its positive relationship
to mercury in ringed seals. On the other hand, the
opposing negative correlation between vitamin E
and cadmium in grey seals does not support the
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Figure 5. Schematic presen-
tation of the relationships be-
tween potential biomarkers
and contaminants in A) ringed
and B) grey seals. The Y-axis
presents the positive and
negative correlation coeffi-
cient between the biochemi-
cal parameter and the pollut-
ant. The PCB congeners CB
126 and CB 153 are pre-
sented as 126 and 153. Uric
acid is presented as UA, vita-
min A in plasma as Vit A pl,
vitamin A in blubber as Vit A
bl, and vitamin A in liver as
Vit A li.
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antioxidising function of vitamin E in cadmium
stress.
The positive correlation between the organic
pollutants and plasma retinol together with the
negative correlation between the contaminants and
blubber and liver retinyl palmitate in grey seals,
could be explained by the increased amounts of
retinol being released from the vitamin A stores,
leading to a depletion of the vitamin A stores in
the Baltic grey seals. As organic contaminants
exert opposing toxic effects on the plasma retinol
levels, reduced retinyl palmitate levels in liver or
blubber are recommended as potential biomarkers
in grey seals. A negative correlation between the
reduced retinoid stores and the elevated hepatic
EROD levels was observed in the grey seals (r <
–0.52, p < 0.05). This has also been observed in
fish, birds and mammals exposed to contaminants
(Murk 1997, Murk et al. 1998, Arcand-Hoy et al.
1999). The lack of a relationship between DDT
or PCB and any of the vitamin A parameters in
ringed seals is interesting as both species showed
reduced hepatic vitamin A in the Baltic Sea.
A species-specific relationship between some
of the clinical blood parameters and the contami-
nants was revealed. The interpretation of these
patterns is difficult for a number of reasons: (1)
Clinical blood parameters have been reported in
marine mammals as baseline values for healthy
captive seals, but have rarely been used as bio-
markers for contaminant exposure or effects; (2)
pathological information about individual seals
is essential if possible toxic effects are to be linked
with the diverging parameters; (3) in human medi-
cine such parameters are used to screen for di-
verging conditions caused by illness or disease,
unlike environmental toxicology where the aim
is to identify effects of contaminants with disease
as a confounding factor (Peakall 1992).
5. Conclusions and future prospects
Do the results presented in this thesis support the
hypotheses postulated? To answer this question,
the hypotheses are presented and the main find-
ings are summarised. Finally, the possible appli-
cations are discussed.
1) CYP1A enzymes are present in ringed
and grey seals, and the individual CYP1A
activity pattern can be used as a sensitive
biomarker for PHAH exposure in ringed
and grey seals.
The results show that CYP1A is present and meas-
urable in both ringed and grey seals. The level of
CYP1A expression is higher in both Baltic seal
populations than in the reference seal populations,
and the individual ∑PCB and ∑DDT loads corre-
late with CYP1A expression. The even distribu-
tion of CYP1A expression among seal tissues sug-
gests that the whole body is susceptible to PHAH
exposure and to its possible toxic effects. Based
on these findings, CYP1A expression is proposed
as an exposure biomarker for both PCB and DDT
contamination in both ringed and grey seals.
When using CYP1A expression as a biomarker
it is important to recognise that the enzyme activ-
ity declines at higher doses of xenobiotics while
the protein level continues to increase with an
increasing PHAH burden (reviewed by Stegeman
and Hahn 1994). Using several methods simulta-
neously for quantifying CYP1A expression can
eliminate this discrepancy. In our studies, both
CYP1A activity and relative protein concentra-
tions were high in the Baltic seal populations.
Furthermore, EROD showed a strong positive
correlation with the protein levels in both
immunoblots and immunohistochemical analyses
(III). Immunohistochemistry proved to be a use-
ful tool for additional qualitative information
about CYP1A localisation, but not as useful for
CYP1A quantification. As it is both ethically and
practically preferable to use non-invasive tech-
niques to study CYP1A expression, the use of ex-
trahepatic tissues such as skin or blood have been
proposed (Fossi et al. 1992, 1999, Goksøyr 1995).
However, there are practical difficulties with this
approach, since it is problematic to extract good
quality microsomes from tissues containing a large
number of different cell types. In addition, the very
low levels of CYP1A in extrahepatic tissues are
not usually revealed by the less sensitive assays
such as immunoblotting. At present, liver
microsomes are the most practical samples for
assaying CYP1A expression. However, the de-
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velopment of methods for CYP1A extraction from
tissues such as blood or skin using minimally in-
vasive techniques is desirable.
2) Other CYP forms may be used as expo-
sure biomarkers for non-planar PCBs and
DDTs.
In addition to the CYP1 family, putative CYP2A
and CYP3A enzymes were found in the seals.
However, these enzymes did not show a higher
expression in the exposed Baltic seals than in the
reference seals. Furthermore, neither of the en-
zymes showed any correlation with the contami-
nant load. Thus, CYP2A and CYP3A cannot be
recommended as exposure biomarkers for non-
planar PCBs and DDTs in ringed and grey seals.
3) CALUX is a tool for measuring the toxic
potency of dioxin-like PHAHs in ringed
seals.
CALUX-TEQ values were higher in the Baltic
ringed seals than in the Svalbard seals, and showed
a strong positive correlation with ∑PCB, ∑PCB-
TEQ and ∑DDT values. Although the CALUX
assay has been developed as a bioindicator of the
toxic potency of the internal load of dioxin-like
substances, it apparently reflects the whole PCB
and DDT burden in ringed seals in this particular
situation. Great advantages of the CALUX assay
are its applicability to practically any tissue, and
its fast and straightforward procedures.
4) Vitamin E levels can be used as an ex-
posure biomarker for contaminants caus-
ing oxidative stress in ringed and grey
seals.
Baltic seals clearly had higher vitamin E concen-
trations than the reference seals, and these levels
correlated with ∑PCB and ∑DDT and mercury
loads, indicating an increased requirement to com-
bat the oxidative stress that is caused by such con-
tamination. On the other hand, it cannot be ex-
cluded that the geographical difference observed
in the vitamin E content is a reflection of differ-
ences in dietary vitamin E levels, until a compari-
son of the vitamin E content in the main food
sources has been conducted. Vitamin E concen-
trations, measured from blubber or plasma, might
be used as an exposure biomarker for xenobiotics
that cause oxidative stress if any possible dietary
impact on the vitamin status could be excluded.
5) A reduced vitamin A store is a biomarker
for the toxic effects of PHAHs in ringed
and grey seals.
Retinyl palmitate levels were clearly lower in the
vitamin A stores of the Baltic seals than of the
reference seals. In grey seals, both hepatic and
blubber retinyl palmitate correlated negatively
with the planar PCBs and ∑DDT. Despite the re-
duction in hepatic retinyl palmitate concentrations
seen in the Baltic ringed seals, this geographical
trend could not clearly be correlated to the indi-
vidual contaminant profiles in this seal species.
The lack of any relationship could be explained
by great individual variations in vitamin A levels,
which could possibly reflect the individual dietary
vitamin A intake. The slightly higher plasma reti-
nol concentrations in the Baltic grey seals than in
the Sable Island seals, and the positive correla-
tion between plasma retinol and DDT and PCBs
further support the hypothesis that contamination
can cause a depletion of the vitamin A stores.
However, the two opposing toxic effects of
PHAHs on plasma retinol levels discourages one
from using this as an indicator of PHAH effects.
To conclude, hepatic and blubber retinyl palmi-
tate levels could be proposed as a biomarker for
the depletion of vitamin A stores in grey seals,
but more information about the vitamin A levels
in the food sources is needed before any conclu-
sions can be drawn. None of the vitamin A-linked
parameters can be proposed as a biomarker in
ringed seals.
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6) Clinical blood parameters reflect the
toxic effects of the contaminant load in
the Baltic seals and can, therefore, be used
as effect biomarkers in ringed and grey
seals.
A correlation between some of the clinical blood
parameters and the contaminants was revealed,
but the great individual variations and small geo-
graphical differences in these parameters make it
difficult to use them as biomarkers. On the other
hand, the analysis of clinical blood parameters
might be a practical and non-invasive tool for as-
saying the general health status of seals provided
that good base-line information is available for
healthy, free-living ringed and grey seals.
7) The two species show a different sus-
ceptibility and response to the contami-
nant load. Therefore, the health status and
contaminant exposure and effects should
be monitored separately in each species.
The clearly higher ∑DDT and ∑PCB levels in
the Baltic ringed seals might explain the differ-
ences in the health status and reproductive fre-
quency between the two Baltic seal species. ∑PCB
concentrations of 70 mg/kg lipid in blubber have
been proposed as a threshold level for the devel-
opment of reproductive impairments in ringed
seals (Helle et al. 1976a,b). Contaminant levels
clearly exceeding that value were measured from
several of the Baltic ringed seals, while only one
Baltic grey seal reached this threshold level (Fig-
ure 3). Furthermore, the TEQ values of the total
PCB load in the Baltic seals are above an esti-
mated threshold level for the toxic effects of these
kinds of compounds in harbour seals (VI). PCB-
TEQ levels of 0.2 ng/g lipid have been estimated
as the level above which harbour seals show
immunotoxic and reproductive effects (Murk
1997). Again the Baltic ringed seals showed mean
PCB-TEQ values of 0.6 ng/lipid, which is clearly
above the threshold level. The differing contami-
nant levels between the two Baltic seal populations
suggest that ringed seals have a lower capacity to
metabolise these compounds than do grey seals,
since the contaminant intake is probably similar
in both species. The Baltic seals feed at approxi-
mately the same trophic level of the Baltic food
web. Furthermore, the PHAH levels in gill breath-
ing animals are very similar regardless of their
trophic position, suggesting that PHAH exposure
is controlled by the contaminant concentrations
in the ambient water rather than in the diet (Tanabe
1988).
EROD activity showed a greater geographi-
cal difference in grey seals than in ringed seals
(Figure 4). However, the geographical difference
of the PHAH load was smaller in grey seals (Fig-
ure 3). This could be explained by a greater ca-
pacity of grey seals to react to an increasing con-
taminant exposure by inducing CYP1A expres-
sion. This hypothesis further supports the previ-
ous suggestion that ringed seals have a lower ca-
pacity to metabolise PHAHs. The variation in both
hepatic and extrahepatic CYP expression patterns
between the two species discourages one from ex-
trapolating between them.
The species differences of some of the bio-
chemical parameters, and their relationship to the
contaminants, is difficult to explain as the ob-
served trends are associated with uncertainties of
various kinds. One possibility is that the two seal
species react in different ways to the toxic effects
of the contaminant load, but to answer these ques-
tions experimental studies should be conducted
to explore the underlying toxic mechanisms.
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